I like this bit of this article
"ResAppDx-EU offers strong health and economic benefits to Telehealth providers, emergency departments and urgent care clinics in Australia and Europe, and we are excited by the scale of the opportunity and our unique position in the market," he added.
ResAppDx-EU is now listed on the Australian Register of Therapeutic Goods (ARTG) as a Class IIa medical device which means the device requires stricter regulatory controls to provide assurance of its effectiveness and safety.
Ping..Ping..Ping...
It is now game on
MB
- Forums
- ASX - By Stock
- RAP
- Receives TGA approval for ResAppDx-EU version 2
Receives TGA approval for ResAppDx-EU version 2, page-2
-
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online